Filing Flows › Comparisons › COLL vs VREOF
Collegium Pharmaceutical vs Vireo Growth: COLL and VREOF compared
Collegium Pharmaceutical is the larger company: $216M of revenue in its latest quarter (Q3 2026) against $209M for Vireo Growth (Q2 2026). Vireo Growth is growing faster (+335% against +3% a year earlier). Collegium Pharmaceutical is more profitable, with an operating margin of 13.3% against -3.0%.
Where the money goes: COLL and VREOF
Collegium Pharmaceutical (COLL) · Q3 2026
Collegium Pharmaceutical, Q3 2026: revenue $216M (+3% year over year), operating margin 13.3%, net earnings $21.8M, operating cash flow $86.5M. The chart follows the revenue to costs, profit and cash.
Vireo Growth (VREOF) · Q2 2026
Vireo Growth, Q2 2026: revenue $209M (+335% year over year), operating margin -3.0%, net loss $100K, operating cash flow $2.4M. The chart follows the revenue to costs, profit and cash.
| Collegium Pharmaceutical (COLL) | Vireo Growth (VREOF) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q2 2026 |
| Revenue | $216M | $209M |
| Revenue growth, Y/Y | +3% | +335% |
| Gross margin | 58.0% | — |
| Operating margin | 13.3% | -3.0% |
| Net earnings | $21.8M | −$100K |
| Net margin | 10.1% | 0.0% |
| Operating cash flow | $86.5M | $2.4M |
| Free cash flow | $86.3M | — |
| Market value | $717M | — |
| P/E | 15.0× | — |
| Analysts’ mean target | $49.00 | — |
Where the revenue comes from
Collegium Pharmaceutical
- Belbuca: $57.7M (27%)
- Jornay PM: $51.9M (24%)
- Xtampza ER: $45.8M (21%)
- Azstarys: $26.5M (12%)
Questions
Which is bigger, Collegium Pharmaceutical or Vireo Growth?
Collegium Pharmaceutical is the larger company: $216M of revenue in its latest quarter (Q3 2026) against $209M for Vireo Growth (Q2 2026).
Is Collegium Pharmaceutical or Vireo Growth growing faster?
Vireo Growth is growing faster (+335% against +3% a year earlier).
Which is more profitable, Collegium Pharmaceutical or Vireo Growth?
Collegium Pharmaceutical is more profitable, with an operating margin of 13.3% against -3.0%.
More: Collegium Pharmaceutical earnings · how Collegium Pharmaceutical makes money · Vireo Growth earnings · how Vireo Growth makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 5, 2026; 10-Q filed Aug 14, 2026). Fiscal quarters can end on different dates. Not investment advice.